about
Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.Immunohistochemical correlates of TP53 somatic mutations in cancerEvaluation of the good tumor response of embryonal tumor with abundant neuropil and true rosettes (ETANTR).Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaDynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementiaCognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study.EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlationsPrognostic Role of the Expression of Invasion-Related Molecules in Glioblastoma.Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.New prognostic score for the prediction of 30-day outcome in spontaneous supratentorial cerebral haemorrhage.Epigenetics of Meningiomas.Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate.Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer's disease.Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration.Injury Leads to the Appearance of Cells with Characteristics of Both Microglia and Astrocytes in Mouse and Human Brain.Reply: Atherosclerosis and vascular cognitive impairment neuropathological guideline.Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers.Exceptional in vivo catabolism of neurodegeneration-related aggregates.Atypical sporadic CJD-MM phenotype with white matter kuru plaques associated with intranuclear inclusion body and argyrophilic grain disease.Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.Meningioma recurrence.Heme Oxygenase-1 Activity as a Correlate to Exercise-Mediated Amelioration of Cognitive Decline and Neuropathological Alterations in an Aging Rat Model of Dementia.Inclusion body myositis - pathomechanism and lessons from genetics.[The role of extracellular matrix components in the invasion of intracranial malignancies].Molecular Mechanisms of Neurodegeneration Related to Hexanucleotide Repeat ExpansionBehavioural and Psychological Symptoms in Neurocognitive Disorders: Specific Patterns in Dementia SubtypesTyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA-Induced Early Onco/Suppressor Gene Expression with Tissue-Specificity in MiceArginine Methyltransferase PRMT8 Provides Cellular Stress Tolerance in Aging Motoneurons.Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer's disease and neocortical Lewy body diseaseGiant Squamous Cell Papilloma of the Eyelid-Diagnostic and Therapeutic ChallengesMicroglia monitor and protect neuronal function through specialized somatic purinergic junctionsProteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's diseaseAn update on blood-based biomarkers for non-Alzheimer neurodegenerative disordersEffects of Physical Exercise Training in the Workplace on Physical Fitness: A Systematic Review and Meta-analysisThe Expressional Pattern of Invasion-Related Extracellular Matrix Molecules in CNS TumorsN-Glycosylation Alteration of Serum and Salivary Immunoglobulin a Is a Possible Biomarker in Oral Mucositis
P50
Q27303472-7BF2DED6-B3EF-4B11-9566-AD71894DC26FQ30360497-86F59C59-1429-4EAF-8DB1-360821E76901Q30993688-E14F3780-B8BD-42E4-AFA8-76A6BBCC12E8Q33708946-B0630079-7A09-4E81-92BC-F088A17081FBQ35022169-C87F932F-D10E-423E-8C68-13B89310F1A4Q36657063-7D98DD0E-4FD7-4A1D-BB54-B198285AFFDEQ37591399-AA3A887D-076C-4DAD-9A86-4E86D77C272CQ39485619-28A15C52-E71E-4746-8E91-278405E2425DQ40552948-9DC7DF88-9EE3-41D0-85C3-3F0037997F19Q41485194-4D4E1D76-AC6A-47EE-98E8-E9D055B5EB98Q41925124-390554BA-DB95-4A8A-B5B6-1DD3D441AFCCQ42407159-032040DF-9DFA-4B12-8820-0C16E6ECD4FCQ43128335-8BD340FA-5AF5-43EF-97AF-6D37E0994A15Q47189812-916E528D-6B05-4D3A-AFAB-73CEE212A1EFQ47751527-64A45015-3B00-4912-B366-5A81FA330B44Q47845295-30FEFAD1-BFBB-4362-9131-44CAAD722F5BQ47869899-A46A7FE7-A9E6-475D-9107-8E83A513E970Q47929342-FEFBC7CE-7BEA-4730-A0F4-47D0AFA7C1C6Q48043354-2BE0531F-D421-4A41-B0E5-F6239B5A40E5Q48275761-9BA317BB-FB73-4121-88A0-B66D382E8820Q48529691-9B357CD3-1893-4894-9366-EB8A6326C5C4Q48616026-2AACB6DE-355A-47A1-809C-F709C7227331Q50551448-7C95D2F5-45DB-448E-BECB-1D08E7C431F9Q52695212-870B7979-CD7F-413F-A775-BEFCC855C744Q53692344-D0E2A739-EBF4-4B06-9003-751617A1FB53Q53816848-15250F26-A798-4EF8-93A2-76A090CD8924Q54418567-C53978FD-C81A-4885-A2FF-6413909BD4E8Q61816243-78C60AC5-4A25-4206-A29C-35340650C5DCQ64077477-AEAEE955-4EAB-4B81-AB91-7A73A6A80CF0Q64265033-6DF0FE66-36BC-4E82-990D-3DAFE129045CQ64986456-BED08F9D-1ABF-46CF-88AE-5B1ED81211E1Q91361850-324AD5C4-E6FF-4844-B280-C7A73E1E2A7EQ91532901-BC306D67-54ED-4431-8C96-FC5B6B91A6F1Q91931672-B5D55D6A-482D-4DB4-93B5-1D4D11CC0301Q92810905-70AAF373-5035-4BFF-8FD4-30BD9B60A93DQ93164263-7705F0C7-053C-4FD4-BBA8-2F401EC02EB5Q93173981-52851A4E-AC76-42FC-A7C4-04492470F3ADQ95358067-42F76833-F9E1-4A70-B176-6235E8F570EBQ96225377-47E88406-8327-4403-A78C-BBBE5FD5AD58
P50
description
researcher
@en
wetenschapper
@nl
name
Tibor Hortobágyi
@en
Tibor Hortobágyi
@nl
type
label
Tibor Hortobágyi
@en
Tibor Hortobágyi
@nl
prefLabel
Tibor Hortobágyi
@en
Tibor Hortobágyi
@nl
P31
P496
0000-0001-5732-7942